Tag: managed entry agreements

Implementation of “Coverage With Evidence Development” Drug Approval Strategies Found Lacking

Value in Health announced the publication of new research from The Netherlands showing important gaps in the deployment of “coverage with evidence development,” a type of pharmaceutical managed entry agreement that gives patients access to treatments while additional evidence is being collected.

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,